What Accesofarm does

Accesofarm, S.A. de C.V. is a 100% Mexican private company and subsidiary of Accesolab that specializes in nuclear medicine and molecular imaging products and services for oncological, cardiac, endocrine, gastrointestinal, neurological, and infectious disease diagnosis and treatment. Founded in 2001 and headquartered in Mexico City, the company operates a centralized radiopharmacy in its headquarters supported by three strategically located regional radiopharmacies in Guadalajara, León, and Monterrey, employing more than 70 professional collaborators. Its core technical capability is single-dose radiopharmaceutical preparation and nationwide authorized logistics for radioactive material, enabled by an in-house cyclotron with the highest production capacity in Mexico and ISO 9001:2015 / ISO 13485 certified processes.

The product portfolio spans Tc99m-based radiopharmaceuticals (Tekcis generator plus nine cold kits including Stamicis, Pulmocis, Osteocis, Nanocis), PET radiopharmaceuticals (18F-FDG, 18F-DOPA, 18F-PSMA, 18F-NaF, 11C-Acetate), therapeutic radiopharmaceuticals (I-131, Y-90, Ga-67, Tl-201), and a contrast media line for radiology (Conray, Optiray, Xenetix, Dotarem, Lipiodol, Azul Patente). The company distributes these alongside nuclear medicine equipment (gamma cameras, gamma probes, radiation detectors, dose calibrators) under exclusive Mexican agreements with global manufacturers including Curium, iBA, Isotopia, CIS Bio International, Guerbet, Bayer, RadQual, and Euromedical.

Accesofarm monetizes through a sales-led, enterprise field-sales motion targeting hospitals and diagnostic imaging centers with a B2B quote-based pricing model and multi-year contracts. Revenue streams include radiopharmaceutical and contrast media sales, equipment distribution, integrated turnkey services for SPECT-CT room establishment (facility construction, CNSNS licensing, equipment installation, ongoing supply), and regulatory advisory. The company's core defensibility rests on its exclusive CNSNS authorization to transport radioactive material nationwide from Tijuana to Cancún using its own fleet, making it the only player with comprehensive national coverage in the Mexican nuclear medicine supply chain.

Name

Accesofarm

Legal name

Accesofarm, SA de CV

Website

https://accesofarm.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Accesofarm is a Mexico-based nuclear medicine and molecular imaging distributor serving hospitals and diagnostic imaging centers with single-dose radiopharmaceuticals, contrast media, equipment, and turnkey SPECT-CT room services enabled by exclusive nationwide CNSNS logistics authorization.

Ownership category

akta.pro rank

Product category

Nuclear Medicine and Molecular Imaging

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Radiopharmacy Compounding & Dispensing (Hospital/Commercial) (HLAIAGAE)

akta.pro secondary industries

Radionuclide Supply Chain & Logistics (Shielding/Transport/Distribution) (HLAIAGAH), Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain) (EUAKAIAE), Diagnostic Radiopharmaceuticals (SPECT/PET Tracers) (HLAIAGAA), Radiopharmaceutical & Nuclear Medicine Distributors (HLAIAJAI), Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)

Keywords

• Nuclear medicine supplies
• Radiopharmaceutical distribution
• Diagnostic imaging products
• Contrast media distribution
• Medical imaging equipment

Headquarters

HQ city

Cuauhtémoc

HQ country

Mexico

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Radiopharmaceutical Sales: Sale of radiopharmaceuticals and radiopharmaceutical kits (SPECT and PET tracers) for nuclear medicine diagnosis and treatment. Includes Tc99m products, Ga-67, I-131, Tl-201, F-18 FDG, and therapeutic agents.
2. Contrast Media and Imaging Supplies: Sale of contrast media for X-Ray, CT, Hemodynamics, and MRI. Includes accessories like syringes and transfer sets.
3. Medical Equipment Distribution: Distribution of gamma cameras, gamma probes, radiation detectors, area monitors, dose calibrators, shielded boxes, lead aprons, and calibration sources.
4. Integrated Services for SPECT-CT Rooms: Turnkey services including facility adaptation/construction, licensing with CNSNS, equipment supply (gamma cameras, SPECT-CT), and radiopharmaceutical single-dose delivery.
5. Licensing and Regulatory Advisory: Regulatory advisory and management services for nuclear medicine and PET-CT licensing before CNSNS including analytical memory and procedure manual preparation.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Accesofarm distributes and supplies unit-dose radiopharmaceuticals for SPECT-CT and PET-CT nuclear medicine procedures, contrast media for radiology and MRI imaging, and nuclear medicine equipment (gamma cameras, probes, detectors) to hospitals, clinics, and diagnostic imaging centers across Mexico. The company additionally provides turnkey integrated services covering SPECT-CT and PET-CT room construction, CNSNS regulatory licensing, equipment installation, and personalized radiopharmaceutical delivery through its own CNSNS-authorized nationwide logistics fleet.

Product overview

Accesofarm is a 100% Mexican company offering a comprehensive portfolio of nuclear medicine and imaging products and services. The core offering centers on radiopharmaceuticals in unit-dose presentations for nuclear medicine diagnosis and treatment, including SPECT-CT and PET-CT radiopharmaceuticals (Tc99m kits, therapeutic isotopes like I-131, Y-90, Ga-67, Tl-201), PET radiopharmaceuticals (18F-FDG, 18F-DOPA, 18F-PSMA, 18F-NaF, 11C-Acetate), and Technetium generators (Tekcis). The imaging division provides contrast media for radiology (Conray, Optiray, Xenetix, Gastroview), MRI contrast agents (Dotarem), and interventional products (Lipiodol, Azul Patente). Supporting services include comprehensive nuclear medicine facility setup (installation, licensing, equipment, personalized doses) and authorized radioactive material logistics. The company operates centralized radiopharmacies in Mexico City, Guadalajara, León, and Monterrey for nationwide coverage.

Differentiator

Problem solved

Functional benefit

Products and services

• Conray Ionic contrast medium for urography, cerebral angiography, peripheral arteriography, venography, arthrography, cholangiography, CT contrast enhancement, and digital subtraction angiography. Sold to hospitals and diagnostic imaging centers.
• Gastroview Oral contrast medium for gastrointestinal imaging studies. Sold to hospitals and diagnostic imaging centers.
• Optiray Iodinated contrast medium available in multiple formulations (350, 320, 300, 240) for angiography, CT, urography, and venography applications. Sold to hospitals and diagnostic imaging centers.
• Xenetix Iodinated contrast medium for urography, angiography, CT, and hemodynamics studies. Sold to hospitals and diagnostic imaging centers.
• Dotarem Gadolinium-based MRI contrast agent for neurological, abdominal, musculoskeletal, and cardiovascular imaging. Sold to hospitals and diagnostic imaging centers.
• Lipiodol Ethiodized poppyseed oil for hysterosalpingography, lymphography, and hepatic arterial use in tumor imaging. Sold to interventional radiology departments.
• Azul Patente Diagnostic agent for lymphatic vessel localization and sentinel lymph node identification in breast cancer patients. Sold to surgical and nuclear medicine departments.
• 18F-FDG (Fluorodeoxyglucose) PET radiopharmaceutical for imaging tumors with increased metabolic activity including adenocarcinomas, sarcomas, and lymphomas. Sold to PET-CT centers.
• 18F-DOPA PET radiopharmaceutical for dopaminergic pathway assessment, Parkinson's evaluation, brain tumors, and neuroendocrine tumors. Sold to PET-CT centers.
• 18F-PSMA Prostate-specific membrane antigen radiopharmaceutical for prostate cancer staging, biochemical recurrence detection, and treatment response assessment. Sold to PET-CT centers.
• 18F-NaF (Sodium Fluoride) Sodium fluoride for bone PET imaging, used for metastatic bone detection, stress fracture suspicion, occult fracture detection, and metabolic bone disease evaluation. Sold to PET-CT centers.
• 11C-Acetato (Carbon-11 Acetate) PET radiopharmaceutical for imaging renal cell carcinoma, hepatocellular carcinoma, prostate cancer, and other malignancies. Sold to PET-CT centers.
• Norchol-131 131I-Iodomethyl Norcholesterol for adrenal cortex functional imaging, metastatic differentiation, and tumor detection. Sold to nuclear medicine departments.
• Galio-67 Citrato (Gallium-67 Citrate) SPECT radiopharmaceutical for lymphoma diagnosis, staging, chemotherapy response assessment, and inflammatory disease imaging. Sold to nuclear medicine departments.
• Talio-201 Cloruro (Thallium-201 Chloride) SPECT radiopharmaceutical for myocardial perfusion imaging, muscle perfusion evaluation, parathyroid imaging, and tumor visualization. Sold to nuclear medicine and cardiology departments.
• Yoduro de Sodio I-131 (Sodium Iodide I-131) Therapeutic radiopharmaceutical for treatment of Graves' disease, toxic multinodular goiter, autonomous nodules, and thyroid carcinoma. Sold to nuclear medicine departments.
• Itrio-90Y Citrato (Yttrium-90 Citrate) Therapeutic radiopharmaceutical for synovial irradiation in treatment of synovial hypertrophy of the knee in inflammatory rheumatic diseases. Sold to nuclear medicine and rheumatology departments.
• Tc99m Kits Line (Stamicis, Technescan PYP, Nanocis, Pulmocis, Pentacis, Renocis, Technescan DTPA, Technescan MAG3, Osteocis, Teceos) Technetium-99m labeling kits for myocardial perfusion, bone scintigraphy, renal studies, pulmonary perfusion, lymphoscintigraphy, and other nuclear medicine procedures. Sold to nuclear medicine departments preparing unit-dose radiopharmaceuticals.
• Tekcis (Technetium-99m Generator) Technetium-99m generator producing eluate for radiopharmaceutical preparation, thyroid imaging, salivary gland imaging, and Meckel's diverticulum localization. Sold to nuclear medicine departments and centralized radiopharmacies.
• Unidosis Radiofarmacéuticas (Unit-Dose Radiopharmaceuticals) Personalized unit-dose radiopharmaceuticals prepared in Accesofarm's centralized radiopharmacies for nuclear medicine departments, including Tc99m-based products and therapeutic isotopes. Delivered nationwide from Tijuana to Cancún.
• Equipamiento de Medicina Nuclear (Nuclear Medicine Equipment) Nuclear medicine equipment including gamma cameras, gamma probes, radiation detectors, dose calibrators, and shielded workstations. Sold to hospitals and diagnostic imaging centers.
• Servicios Integrales (Integrated SPECT-CT/PET-CT Services) Comprehensive turnkey services for nuclear medicine facility establishment, including facility construction, installation, CNSNS licensing, equipment supply, and personalized radiopharmaceutical delivery. Sold to hospitals and clinics establishing or upgrading nuclear medicine capabilities.
• Logística de Material Radiactivo (Radioactive Material Logistics) Authorized logistics service for radioactive material delivery covering the entire national territory from Tijuana to Cancún, using Accesofarm's own CNSNS-authorized vehicle fleet. Sold to nuclear medicine departments and centralized radiopharmacies.
• Asesoría y Gestoría (CNSNS Licensing Advisory) Regulatory advisory and management services for nuclear medicine and PET-CT licensing before CNSNS, including analytical memory and procedure manual preparation. Sold to hospitals and clinics establishing nuclear medicine operations.

Quantifiable outcome

• Immediate delivery of personalized single doses to nuclear medicine facilities
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• CuriumcoreChannel Partner/ Reseller/ DistributorCurium branded nuclear medicine products distributed by Accesofarm in Mexico including SPECT and PET radiopharmaceuticals.
• iBAcoreChannel Partner/ Reseller/ DistributoriBA nuclear medicine products and technologies distributed by Accesofarm in Mexico for PET-CT and radiopharmaceutical production.
• IsotopiacoreChannel Partner/ Reseller/ DistributorIsotopia radiopharmaceutical products distributed by Accesofarm in the Mexican market.
• EuromedicalminorChannel Partner/ Reseller/ DistributorEuromedical medical equipment products distributed by Accesofarm in Mexico.
• GuerbetcoreChannel Partner/ Reseller/ DistributorGuerbet contrast media products including Dotarem for MRI distributed by Accesofarm in Mexico.
• BayercoreChannel Partner/ Reseller/ DistributorBayer contrast media and imaging products including Ultravist distributed by Accesofarm in Mexico.
• RadQualminorChannel Partner/ Reseller/ DistributorRadQual radiopharmaceutical products and kits distributed by Accesofarm in Mexico.
• CIS Bio InternationalcoreChannel Partner/ Reseller/ DistributorCIS Bio International radiopharmaceutical products including Norchol-131, Thallium 201, Gallium 67, and Yttrium 90 distributed in Mexico.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Bracco Imaging: Global contrast media and imaging diagnostic company. Comparable to Accesofarm's imaging division (Conray, Optiray, Dotarem distribution), operating as a manufacturer-incumbent rather than a regional distributor.
• Guerbet: French contrast media manufacturer (Dotarem, Lipiodol). Accesofarm distributes Guerbet products in Mexico, making Guerbet a relevant peer in the imaging contrast media category.
• Siemens Healthineers: Global imaging OEM offering PET-CT, SPECT-CT, and laboratory diagnostics. Comparable to Accesofarm in the nuclear medicine equipment and imaging supply chain, though from a broader capital equipment and software perspective.
• Cardinal Health (Nuclear & Precision Health): Operates one of the largest US radiopharmacy distribution networks. Comparable business model to Accesofarm's centralized radiopharmacy with nationwide logistics, though materially larger and US-focused.
• GE HealthCare: Major incumbent in molecular imaging, supplying SPECT/PET scanners, radiopharmaceuticals, and contrast media. Overlaps with Accesofarm across both equipment distribution and radiopharma supply, but operates globally across many other modalities.

Direct peers

• Curium: Global nuclear medicine manufacturer of SPECT and PET radiopharmaceuticals. Curium is both a direct competitor (radiopharma supply) and a partner (Accesofarm distributes Curium products in Mexico), making it the most directly comparable peer in the radiopharmaceutical value chain.
• iBA (Ion Beam Applications): Manufacturer of cyclotrons and PET radiopharma production equipment. Accesofarm distributes iBA products, and iBA's cyclotron technology underpins Accesofarm's own production capacity, making it directly comparable in the nuclear medicine supply chain.
• Lantheus Holdings: US-listed diagnostic radiopharmaceutical company (e.g., TechneLite, Xenon, PyL). Closely comparable to Accesofarm's Tc99m kits and PET tracer portfolio in product category, though focused on US/global markets rather than Mexico.
• Accesolab: Accesofarm is a wholly-owned subsidiary of Accesolab. Accesolab supplies instrumentation, reagents, and consumables for research, medicine, and industry, overlapping with Accesofarm's distribution and laboratory diagnostics activities.

Emerging players

• Telix Pharmaceuticals: Theranostics and diagnostic radiopharmaceutical company with PSMA-targeted imaging agents (Illuccix). Directly competes in the same PET tracer and therapeutic radiopharmaceutical categories Accesofarm distributes (e.g., 18F-PSMA).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AccesoFarm
• LinkedInlinkedin.com/company/accesofarm

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accesofarm